IP Library Granted Patent US 10,758,504
Granted Patent B2
US 10,758,504 · App. 15/267,717 · Granted Sep 1, 2020

Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma

Inventors: Shawn Baier (Polk City, IA); Naji Abumrad (Nashville, IA); Emily Harris (Des Moines, IA)
Assignee: Metabolic Technologies, Inc.
A61K31/19A61P19/04A61P21/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,758,504
App. No.
15/267,717
Filed
Sep 16, 2016
Granted
Sep 1, 2020
Kind
B2
Art Unit
1627
USPC
514/557
Abstract

The present invention provides a composition comprising HMB. Methods of administering HMB to an animal are also described. HMB is administered to enhance recovery from soft tissue trauma, including both acute and non-acute soft tissue trauma. Enhanced recovery includes reduced recovery time and enhanced soft tissue healing.

Claims (21)

1. A method of enhancing recovery from acute soft tissue injury, comprising administering to a human in need thereof a composition comprising from about 0.001 to 0.2 grams of β-hydroxy-β-methylbutyric acid (HMB) per kilogram of body weight, wherein the HMB further comprises HMB in its free acid form, its salt, its ester or its lactone, and wherein soft tissue is selected from the list consisting of tendons, and ligaments.

2. The method of claim 1 , wherein recovery from the soft tissue injury is improved relative to recovery from soft tissue injury in a human not administered said composition.

3. The method of claim 1 , wherein said salt is selected from the group consisting of a sodium salt, a potassium salt, a magnesium salt, a chromium salt, and a calcium salt.

4. The method of claim 1 , wherein the composition is administered in the amount of 0.5 g to 30 g.

5. A method of reducing recovery time from acute soft tissue injury, comprising administering to a human in need thereof a composition comprising from about 0.001 to 0.2 grams of β-hydroxy-β-methylbutyric acid (HMB) per kilogram of body weight, wherein the HMB further comprises HMB in its free acid form, its salt, its ester or its lactone and wherein soft tissue is selected from the list consisting of muscle, tendons, and ligaments.

6. The method of claim 5 , wherein the recovery time is shorter for the human administered the composition relative to the recovery time in a human not administered said composition.

7. The method of claim 5 , wherein said salt is selected from the group consisting of a sodium salt, a potassium salt, a magnesium salt, a chromium salt, and a calcium salt.

8. The method of claim 5 , wherein the composition is administered in the amount of 0.5 grams to 30 grams.

9. The method of claim 5 , wherein the composition is administered for a period of days, weeks or months subsequent to the soft tissue injury.

10. A method of improving healing from acute soft tissue injury, comprising administering to a human in need thereof a composition comprising from about 0.001 to 0.2 grams of β-hydroxy-β-methylbutyric acid (HMB) per kilogram of body weight, and wherein soft tissue is selected from the list consisting of tendons, ligaments.

11. The method of claim 10 , wherein the soft tissue healing is improved for the human administered the composition relative to the soft tissue healing in a human not administered said composition.

12. A method of enhancing recovery from non-acute soft tissue trauma, comprising administering to an human in need thereof a composition comprising from about 0.001 to 0.2 grams of β-hydroxy-β-methylbutyric acid (HMB) per kilogram of body weight wherein the HMB further comprises HMB in its free acid form, its salt, its ester or its lactone, and wherein the non-acute trauma is selected from the list consisting of tendonitis, bursitis, carpal tunnel syndrome, and plantar fasciitis.

13. The method of claim 12 , wherein the repair of the soft tissue trauma is improved for the human administered the composition relative to repair of the soft tissue trauma in a human not administered said composition.

14. The method of claim 1 , wherein the acute injury is selected from the list consisting of surgery, Achilles tendon rupture or tear, anterior cruciate ligament rupture or tear, medial collateral ligament rupture or tear, elbow ligament tear, tendon tear, sprains, strains, rotator cuff tear and shoulder injuries.

15. The method of claim 1 , wherein enhanced recovery further comprises healing, regeneration or repair of the soft tissue.

16. A method of reducing recovery time from surgery, comprising administering to a human about to undergo, undergoing or just having undergone surgery a composition comprising from about 0.001 to 0.2 grams of β-hydroxy-β-methylbutyric acid (HMB) per kilogram of body weight, wherein the type of surgery is orthopedic surgery, shoulder surgery, elbow surgery, hand surgery, hip surgery, knee surgery, ankle surgery, or spinal surgery.

17. A method for enhancing recovery in a surgical patient comprising administering to the patient a composition comprising from about 0.5 to about 30 grams of β-hydroxy-β-methylbutyric acid (HMB) wherein administration of the composition begins prior to surgery, during surgery or post-surgery and wherein the type of surgery is orthopedic surgery, shoulder surgery, elbow surgery, hand surgery, hip surgery, knee surgery, ankle surgery, or spinal surgery.

18. The method of claim 17 , wherein enhanced recovery further comprises improved healing, regeneration or repair of soft tissue.

19. The method of claim 17 , wherein recovery from surgery is improved relative to recovery from surgery in a patient not administered said composition.

20. The method of claim 17 , wherein the HMB further comprises HMB in its free acid form, its salt, its ester or its lactone.

21. A method of expediting the repair or regeneration of soft tissue that has been subjected to acute injury comprising administering to a human in need thereof a composition comprising from about 0.5 to about 30 grams of β-hydroxy-β-methylbutyric acid (HMB), wherein the soft tissue is selected from the list consisting of tendons and ligaments.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2016
From: BAIER, SHAWN; ABUMRAD, NAJI; HARRIS, EMILY
To: METABOLIC TECHNOLOGIES, INC.
Reel/Frame 040360/0956 →
Continuity (2)
Provisional Application 62219208 · Sep 16, 2015
Related Publication 20170071886A1 · Mar 16, 2017